人类胆载体的多样性:基质特异性,运动性质和抑制剂敏感性
Kyra-Elisa Maria Redeker1, Jürgen Brockmöller1
1Institute of Clinical Pharmacology, University Medical Center Göttingen D-37075 Göttingen, Germany.
Biochemical pharmacology
|September 19, 2025
概括
这项研究比较了参与细胞胆吸收的16种溶解物载体 (SLC) 蛋白. SLC5A7显示出最高的效率,七个SLC与生理胆水平保持一致,影响运动和认知功能.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 载体介导的胆吸收对于乙胆生物合成和其他生物过程至关重要.
- 已知16种溶解物载体 (SLC) 蛋白质可能有助于细胞胆的透.
- 缺乏对这些SLC蛋白的生化功能进行实验性比较.
研究的目的:
- 为了实验性地比较16种过度表达的SLC蛋白的胆运输动力学.
- 评估这些SLCs的胆类同类和相关代谢物的运输.
- 为了研究这些载体对像hemicholinium-3这样的抑制剂的敏感性.
主要方法:
- 过度表达具有已知的胆运输能力的16种SLC蛋白质.
- 对胆运输动力学和基质特异性的比较分析.
- 对抑制剂敏感性的评估,包括hemicholinium-3,decynium-22和verapamil.
主要成果:
- 七个SLCs (SLC5A7,SLC35F2-4,SLC25F5,SLC35G4,SLC44A5) 显示了生理胆吸收动力学 (12-50μM KM).
- SLC5A7表现出最高的内在清除率,明显超过其他载体.
- 在SLC5A7和SLC35F2-5中,SLC35G4对海米-3,-22和维拉帕米尔表现出敏感性.
结论:
- 多个SLCs有助于人类的细胞胆吸收,受生理条件和表达模式的影响.
- 了解这些载体可能会阐明对运动和认知功能的遗传和环境影响.
- 这项研究提供了关键胆载体的比较生化特征.
更多相关视频
相关概念视频
The Significance of Membrane Transport
41.0K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
41.0K
Nonlinear Pharmacokinetics: Role of Transporters
282
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
282
Hepatic Drug Clearance: Role of Transporters
297
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
297
Cholinesterases: Distribution and Function
961
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
961
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.8K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.8K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
278
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
278


